Your browser doesn't support javascript.
loading
Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity.
Zheng, Tony J; Kohs, Tia C L; Mueller, Paul A; Pang, Jiaqing; Reitsma, Stéphanie E; Parra-Izquierdo, Iván; Melrose, Alexander R; Yang, Liping; Choi, Jaewoo; Zientek, Keith D; Sviridov, Denis O; Larson, Mark K; Williams, Craig D; Pamir, Nathalie; Shatzel, Joseph J; Reddy, Ashok P; Kievit, Paul; Remaley, Alan T; Stevens, Jan F; Hinds, Monica T; McCarty, Owen J T; Aslan, Joseph E.
Afiliación
  • Zheng TJ; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • Kohs TCL; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • Mueller PA; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.
  • Pang J; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • Reitsma SE; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • Parra-Izquierdo I; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • Melrose AR; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.
  • Yang L; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.
  • Choi J; Department of Chemistry, Oregon State University, Corvallis, OR.
  • Zientek KD; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR.
  • Sviridov DO; Proteomics Shared Resource, Oregon Health & Science University, Portland, OR.
  • Larson MK; Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Williams CD; Department of Biology, Augustana University, Sioux Falls, SD.
  • Pamir N; College of Pharmacy, Oregon State University, Corvallis, OR.
  • Shatzel JJ; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR.
  • Reddy AP; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • Kievit P; Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR.
  • Remaley AT; Proteomics Shared Resource, Oregon Health & Science University, Portland, OR.
  • Stevens JF; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR.
  • Hinds MT; Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • McCarty OJT; College of Pharmacy, Oregon State University, Corvallis, OR.
  • Aslan JE; Linus Pauling Institute, Oregon State University, Corvallis, OR.
Blood Adv ; 7(8): 1366-1378, 2023 04 25.
Article en En | MEDLINE | ID: mdl-36219587
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Hemostáticos Límite: Animals / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Hemostáticos Límite: Animals / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos